Effects of dapagliflozin in heart failure with preserved ejection fraction and chronic obstructive pulmonary disease: an analysis of the DELIVER trial

27 August 2023 (08:48 - 09:06)
Organised by: Logo
Congress Presentation Part of: State-of-the art treatment of HFmrEF and HFpEF in 2023 Treatment ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology